Delivery Order SPE2DB20D1100-SPE2DB25FE3T9
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $60K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a Delivery Order contract by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This firm fixed price delivery order, valued at $11,576.19, represents a non-competitive award under DLA's pharmaceutical supply chain supporting federal medical procurement needs. The contract is scheduled for completion by August 6, 2025, with performance originating from AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $274,266.46 by the Defense Logistics Agency's Medical Supply Chain to supply RINVOQ ER 45 mg tablets in a quantity of 28 units. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $14,917.09 for RINVOQ ER 30 MG Tablet (UU 30s) by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and is classified as a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $40,276.41 by the Defense Logistics Agency on August 4, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, by the Defense Logistics Agency to supply RINVOQ ER 15 mg tablets in quantities of 30 units. The contract carries a firm fixed price ceiling value of $31,161.95 and is scheduled for completion by August 15, 2025. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded delivery order representing a standard transaction within the...
- The Defense Logistics Agency awarded a delivery order valued at $37,122.24 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $26,154.99 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of RINVOQ ER 30 mg tablets (quantity: 30-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,638.89 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award status. The contract is set to complete on August 12, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...